Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Slow Wave Sleep in Critically Ill Patients
NCT04818450Completed
- Sponsor
- Mahidol University
- Start
- Apr 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of gabapentin in sleep deprivation, sponsored by Mahidol University. Primary endpoint: Slow-wave sleep at 3 days. Started Apr 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
sleep deprivation
Beyond the preview
Go deeper on NCT04818450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818450.